Becker M - Search Results

1

Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.

Rolff J, Becker M, Merk J, Hoffmann J, Fichtner I. Rolff J, et al. Among authors: becker m. Target Oncol. 2016 Aug;11(4):507-14. doi: 10.1007/s11523-015-0415-4. Target Oncol. 2016. PMID: 26817645

2

Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives.

Naundorf H, Rewasowa EC, Fichtner I, Büttner B, Becker M, Görlich M. Naundorf H, et al. Among authors: becker m. Breast Cancer Res Treat. 1992;23(1-2):87-95. doi: 10.1007/BF01831480. Breast Cancer Res Treat. 1992. PMID: 1446057

3

Development of a mitoxantrone-resistant P 388 in vivo: approaches to overcome resistance.

Fichtner I, Becker M, Lemm M, Winterfeld G. Fichtner I, et al. Among authors: becker m. Oncology. 1990;47(6):508-15. doi: 10.1159/000226881. Oncology. 1990. PMID: 1700851

4

In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.

Fichtner I, Becker M, Zeisig R, Sommer A. Fichtner I, et al. Among authors: becker m. Eur J Cancer. 2004 Apr;40(6):845-51. doi: 10.1016/j.ejca.2003.11.030. Eur J Cancer. 2004. PMID: 15120040 Review.

5

Carboplatin-liposomes as activators of hematopoiesis.

Fichtner I, Reszka R, Schütt M, Rudolph M, Becker M, Lemm M, Richter J, Berger I. Fichtner I, et al. Among authors: becker m. Oncol Res. 1993;5(2):65-74. Oncol Res. 1993. PMID: 8364255

6

Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.

Dehmel A, Becker M, Lemm M, Fichtner I. Dehmel A, et al. Among authors: becker m. Anticancer Res. 1999 May-Jun;19(3A):1977-87. Anticancer Res. 1999. PMID: 10470143

7

Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.

Hoffmann J, Schmidt-Peter P, Hänsch W, Naundorf H, Bunge A, Becker M, Fichtner I. Hoffmann J, et al. Among authors: becker m. Clin Cancer Res. 1999 Aug;5(8):2198-204. Clin Cancer Res. 1999. PMID: 10473106

8

Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations.

Naundorf H, Jost-Reuhl B, Becker M, Reuhl T, Neumann C, Fichtner I. Naundorf H, et al. Among authors: becker m. Breast Cancer Res Treat. 2000 Mar;60(1):81-92. doi: 10.1023/a:1006334131241. Breast Cancer Res Treat. 2000. PMID: 10845812

9

Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL).

Fichtner I, Becker M, Baumgart J. Fichtner I, et al. Among authors: becker m. Eur J Cancer. 2003 Apr;39(6):801-7. doi: 10.1016/s0959-8049(02)00767-0. Eur J Cancer. 2003. PMID: 12651206

10

Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.

Fichtner I, Slisow W, Gill J, Becker M, Elbe B, Hillebrand T, Bibby M. Fichtner I, et al. Among authors: becker m. Eur J Cancer. 2004 Jan;40(2):298-307. doi: 10.1016/j.ejca.2003.10.011. Eur J Cancer. 2004. PMID: 14728946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,076 results

Search Page

Filters